Universal Biosensors Income Statement

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	5.95	6.28	6.63	4.52	5.78	3.2
Revenue Growth (YoY)	-16.52%	-5.28%	46.58%	-21.68%	80.41%	-53.57%
Cost of Revenue	4.36	2.28	2.35	2.39	3.67	2.58
Gross Profit	1.59	4	4.28	2.14	2.11	0.62
Selling, General & Admin	15.95	16.03	15.17	11.35	6.05	6.42
Research & Development	4.98	4.13	4.84	12.02	8.92	4.53
Operating Expenses	21.59	20.97	20.97	26.02	17.14	13.18
Operating Income	-20	-16.97	-16.68	-23.88	-15.04	-12.56
Interest Expense	-0.01	-0.02	-0.02	-0.02	-	-
Interest & Investment Income	0.33	0.45	0.73	0.38	0.05	0.29
Currency Exchange Gain (Loss)	-0.08	-0.01	-0.03	-0.12	0.27	-0.17
Other Non Operating Income (Expenses)	2.3	2.31	9.23	4.74	4.05	2.86
EBT Excluding Unusual Items	-17.46	-14.24	-6.76	-18.89	-10.66	-9.58
Asset Writedown	-	-	-	-11.01	-	-
Other Unusual Items	-	-	0.02	-	0.15	1.27
Pretax Income	-17.46	-14.24	-6.74	-29.91	-10.51	-7.64
Income Tax Expense	-	-	-	-3.05	-	-
Net Income	-17.46	-14.24	-6.74	-26.85	-10.51	-7.64
Net Income to Common	-17.46	-14.24	-6.74	-26.85	-10.51	-7.64
Shares Outstanding (Basic)	298	270	212	199	178	178
Shares Outstanding (Diluted)	298	270	212	199	178	178
Shares Change (YoY)	31.15%	27.32%	6.87%	11.82%	0.08%	0.05%
EPS (Basic)	-0.06	-0.05	-0.03	-0.14	-0.06	-0.04
EPS (Diluted)	-0.06	-0.05	-0.03	-0.14	-0.06	-0.04
Free Cash Flow	-13.31	-12.71	-16.09	-16.27	-10.56	-8.68
Free Cash Flow Per Share	-0.04	-0.05	-0.08	-0.08	-0.06	-0.05
Gross Margin	26.73%	63.70%	64.60%	47.27%	36.45%	19.46%
Operating Margin	-336.03%	-270.08%	-251.48%	-527.72%	-260.28%	-392.12%
Profit Margin	-293.32%	-226.65%	-101.64%	-593.48%	-181.85%	-238.49%
Free Cash Flow Margin	-223.71%	-202.35%	-242.62%	-359.50%	-182.79%	-270.97%
EBITDA	-19.34	-16.17	-15.71	-21.09	-12.47	-10.13
EBITDA Margin	-	-257.30%	-236.86%	-	-215.85%	-
D&A For EBITDA	0.65	0.8	0.97	2.79	2.57	2.43
EBIT	-20	-16.97	-16.68	-23.88	-15.04	-12.56
EBIT Margin	-	-270.08%	-251.48%	-	-260.28%	-
Revenue as Reported	5.95	6.28	6.63	4.52	5.78	3.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.